Data as of Sep 19
| +0.02 / +2.53%|
The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 1.25, with a high estimate of 1.50 and a low estimate of 1.00. The median estimate represents a +54.32% increase from the last price of 0.81.
The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.